NCT00926575View on ClinicalTrials.gov

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

PHASE3TerminatedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

May 31, 2012

Conditions
Acute Gastrointestinal Graft vs Host Disease
Interventions
DRUG

oral beclomethasone 17,21-dipropionate

Two tablets QID for 50 days

DRUG

Placebo

Two tablets QID for 50 days

Trial Locations (3)

Unknown

Buffalo

Durham

Seattle

Sponsors

Lead Sponsor

Soligenix
All Listed Sponsors
lead

Soligenix

INDUSTRY